NEOMYCIN-POLYMYXIN-HC EAR SUSP

neomycin and polymyxin B sulfates and hydrocortisone otic
$4.0109per ML

Strength

10; 3.5; 10000 mg/mL; mg/mL; [USP'U]/mL

NDC

64980044801

Classification

Generic

Dosage Form

SUSPENSION

Route

AURICULAR (OTIC)

Last Updated

4/22/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA060613

On Market Since

3/15/2019

Pharmacological Classes

Aminoglycoside Antibacterial
Aminoglycosides
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Polymyxin-class Antibacterial
Polymyxins

Price History

1W

0.0%

1M

-0.6%

3M

-0.7%

6M

-7.3%

1Y

-12.6%

3Y

-23.4%

5Y

-28.4%

All

-31.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.